Cost-effectiveness of anastrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer

Authors: Simons W.R.; Jones D.; Buzdar A.

Source: Clinical Therapeutics, Volume 25, Number 11, November 2003 , pp. 2972-2987(16)

Publisher: Elsevier

Keywords: breast cancer; anastrozole; tamoxifen; cost-effectiveness; managed care

Language: English

Document Type: Research article

DOI: http://dx.doi.org/10.1016/S0149-2918(03)80348-X

Affiliations: 1: Global Health Economics & Outcomes Research Inc., Summit, , New Jersey, USA

Publication date: 2003-11-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology
• By this author: Simons W.R. ;  Jones D. ;  Buzdar A.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers